Characteristics of patients with advanced cancer preferring not to know prognosis: A multicenter survey study

Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: Progress and challenges

11 p | 4 | 3

Stroke as initial manifestation of non-small cell lung cancer with Trousseau syndrome

9 p | 3 | 2

Triplet versus doublet neoadjuvant chemotherapy regimens for locally advanced gastric cancer: A propensity score matching analysis

11 p | 7 | 2

Pre-treatment expectations of patients with spinal metastases: What do we know and what can we learn from other disciplines? A systematic review of qualitative studies

16 p | 13 | 2

Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: Results of the prospective observational EvAluate-TM study

9 p | 12 | 2

Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: A case comparison study

9 p | 40 | 2

Eribulin improved the overall survival from the initiation of first-line chemotherapy for HER2-negative advanced breast cancer: A multicenter retrospective study

10 p | 15 | 1

Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer

14 p | 2 | 1